title: Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study.
authors.affiliation: Department of Epidemiology, University of Washington, and Seattle Epidemiologic Research and Information Center of the Department of Veterans Affairs Office of Research and Development, Seattle, WA
authors.forename: Nicholas L
authors.initials: NL
authors.lastname: Smith
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Wiley
authors.forename: Claudine
authors.initials: C
authors.lastname: Legault
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Rice
authors.forename: Susan R
authors.initials: SR
authors.lastname: Heckbert
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Psaty
authors.forename: Russell P
authors.initials: RP
authors.lastname: Tracy
authors.forename: Mary
authors.initials: M
authors.lastname: Cushman
mesh_terms: D000941:Antigens / Q000187:drug effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005167:Factor VII / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects*; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D011374:Progesterone / Q000009:adverse effects*; D011446:Prospective Studies; D011486:Protein C / Q000187:drug effects
chemical_list: D000941:Antigens; D004966:Estrogens, Conjugated (USP); D017395:Plasminogen Activator Inhibitor 1; D011486:Protein C; C042580:factor VII clotting antigen; D011374:Progesterone; D005167:Factor VII; D017258:Medroxyprogesterone Acetate